Pilot Study of a Modified Mediterranean Diet Versus Standard Western Diet
in Adults With Metastatic Colorectal Cancer Receiving Chemotherapy
Led by Azienda Socio Sanitaria della Brianza · Updated on 2025-01-27
40
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating how a Modified Mediterranean Diet affects the diversity of gut bacteria in patients with metastatic colorectal cancer who are receiving chemotherapy with or without biological agents. The study compares this diet to a typical Western or standard diet to understand its influence on protecting the intestinal barrier and its potential impact on disease side effects and quality of life.
Participants will be randomly assigned to one of two groups one following the Modified Mediterranean Diet, which emphasizes high-quality prebiotic fibers but reduces total fiber intake to ease chemotherapy side effects, and the other continuing their usual Western diet. The study includes a screening visit, a baseline visit where nutritional status and various measurements are taken, and follow-up visits approximately every 15 to 21 days. Stool samples will be collected at about 45 days and 90 days after baseline, with radiological re-evaluations performed as part of routine care.
During the study, patients will undergo nutritional assessments, blood tests, bioimpedance analysis, and lifestyle evaluations. Researchers will monitor changes in gut microbiota composition, gastrointestinal side effects, and quality of life over time. The primary outcome is the effect of the diet on microbiota after 45 days, with additional measures including changes in microbiome composition and metabolome at baseline, 45 days, and 90 days. The total participation period includes visits up to 90 days after starting the diet intervention.
CONDITIONS
Brief Title
Study on the Impact of a Modified Mediterranean Diet, in Patients With Colorectal Cancer Undergoing Active Medical Oncology Treatment
Research Team
S
Salvatore Artale, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Eastern Cooperative Oncology Group performance status (ECOG) of 0 or 1
Age 18 to 80 years
Diagnosis of metastatic colorectal cancer confirmed by histology and imaging according to RECIST 1.1 criteria
Currently receiving first-line chemotherapy treatment with or without biological agents (anti-EGFR, anti-VEGF)
Malnutrition Universal Screening Tool (MUST) score of 0 or 1
Signed written informed consent
You will not qualify if you...
Previous oncological medical therapies
Need for parenteral and/or enteral nutrition
Malnutrition Universal Screening Tool (MUST) score greater than 2
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for screening and enrollment
Treatment
Duration - Approximately 90 days
Participants follow either a modified Mediterranean diet or continue their usual diet while undergoing active medical oncology treatment. Nutritional status and biological samples are collected to assess the impact of diet on intestinal microbiota and clinical outcomes.
Visits every 15 or 21 days depending on ongoing therapy, including stool sample collections at around 45 and 90 days
Follow-up
Duration - Single visit at approximately 90 days after baseline
Participants undergo radiological re-evaluation as part of clinical practice to assess treatment outcomes after approximately 90 days from baseline.
1 visit (in-person)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Evaluating Photobiomodulation Therapy for Oral Chronic Graft-Versus-Host Disease After Stem Cell Transplant Using the Thor LX2.3 Device A Phase II Randomized Double-Blind Trial
Pilot Study of a Modified Mediterranean Diet Versus Standard Western Diet
in Adults With Metastatic Colorectal Cancer Receiving Chemotherapy
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The Effects of a Modified Mediterranean Diet on Gut Microbiota and Chemotherapy Side Effects in Patients With Metastatic Colorectal Cancer Undergoing First-Line Chemotherapy With or Without Either Antiepidermal Growth Factor Receptor or Antivascular Endothelial Growth Factor Agent: Protocol for a Randomized Pilot Study in Italy.
Salvatore Artale, Francesca Filiali, Elena Beretta...